SCHEMBL730964

SCHEMBL730964

Fc1ccccc1-c1c[c]cc(-c2nnn[nH]2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCUN1D1 Q96GG9 2/20 0.38
IDO1 P14902 1/20 0.37
NPC1 O15118 3/20 0.36
MPL P40238 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALDH1A1 P00352 2/20 0.36
PKM P14618 1/20 0.36
RAB9A P51151 1/20 0.36
MAP4K1 Q92918 2/20 0.35
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
LMNA P02545 1/20 0.33
KMT2A Q03164 1/20 0.33
TRPA1 O75762 1/20 0.33
KDM5B Q9UGL1 1/20 0.32
MGAM O43451 1/20 0.32
GAA P10253 1/20 0.32
SI P14410 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023996 0.79 DCUN1D1 (0.47) DCUN1D1IDO1NPC1L3MBTL1ALDH1A1
SCHEMBL1773738 0.79 DCUN1D1 (0.47) DCUN1D1IDO1NPC1L3MBTL1ALDH1A1
SCHEMBL733019 0.78 MEN1 (0.39) DCUN1D1NPC1L3MBTL1ALDH1A1RAB9A
SCHEMBL730958 0.78 RAB9A (0.33) NPC1L3MBTL1ALDH1A1RAB9AKMT2A
SCHEMBL732981 0.74 IDO1 (0.40) IDO1NPC1RAB9ACASP3SENP8
SCHEMBL5251206 0.70
SCHEMBL12075530 0.69 MEN1 (0.36) L3MBTL1ALDH1A1RAB9ALMNAKMT2A
SCHEMBL5802414 0.69 GRK6 (0.41) DCUN1D1NPC1L3MBTL1ALDH1A1PKM
SCHEMBL12615990 0.69 ALDH1A1 (0.38) DCUN1D1IDO1L3MBTL1ALDH1A1KMT2A
SCHEMBL731569 0.69 F2RL3 (0.34) NPC1ALDH1A1PKMRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 DCUN1D1 2150/4885IDO1 280/4885NPC1 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.